13 December 2023 - NICE has published final evidence-based recommendations on the use of pembrolizumab (Keytruda) and chemotherapy with or ...
12 December 2023 - NICE has published further draft guidance on the use of efgartigimod for the treatment of patients ...
7 December 2023 - NICE is unable to make a recommendation on the use of dupilumab (Dupixent) for the treatment of ...
6 December 2023 - NICE has published final evidence-based recommendations on the use of secukinumab (Cosentyx) for the treatment of ...
1 December 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
29 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
30 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
29 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
29 November 2023 - NICE is unable to make a recommendation on the use of tisagenlecleucel (Kymriah) for the treatment of ...
29 November 2023 - NICE has published final evidence-based recommendations on the use of foslevodopa with foscarbidopa (Produodopa) for the ...
27 November 2023 - Infants with a rare and fatal congenital disorder called Wolman disease in England and Wales will ...
24 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
23 November 2023 - NICE is unable to make a recommendation on the use of cedazuridine with decitabine (Inaqovi) for the ...
22 November 2023 - NICE has published final evidence-based recommendations on the use of zanubrutinib (Brukinsa) for the treatment of ...
20 November 2023 - NICE’s methods and processes for evaluating new treatments for use in the NHS are appropriate for the ...